[CONSIDERATIONS ON THE USE OF LIQUID HYDRAZIDE IN AEROSOL FORM AS THE SOLE MEDICATION AND AS AN ADJUVANT TO 1ST-LINE TUBERCULOSTATIC AGENTS BY ORAL ROUTE, IN THE TREATMENT OF PULMONARY AND LARYNGEAL TUBERCULOSIS. EXPERIENCE WITH 31 CASES].
D000336:Aerosols; D000995:Antitubercular Agents; D006801:Humans; D007538:Isoniazid; D010406:Penicillins; D013902:Radiography, Thoracic; D013307:Streptomycin; D014376:Tuberculosis; D014387:Tuberculosis, Laryngeal; D014397:Tuberculosis, Pulmonary
D000336:Aerosols; D000995:Antitubercular Agents; D010406:Penicillins; D007538:Isoniazid; D013307:Streptomycin
AEROSOLS; ISONIAZID; PENICILLIN; STREPTOMYCIN; THORACIC RADIOGRAPHY; TUBERCULOSIS, LARYNGEAL; TUBERCULOSIS, PULMONARY
CONSIDERA C OES S OBRE O EMPR EGO DA HIDRAZIDA L'IQUIDA EM AEROSOL COMO MEDICA C AO 'UNICA E COMO COADJUVANTE DOS TUBERCULOST'ATICOS DE PRIMEIRA LINHA POR VIA ORAL, NO TRATAMENTO DA TUBERCULOSE PULMONAR E LAR'INGEIA. EXPERI ENCIA COM 31 CASOS.